Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Shashwat Goenka takes over as Vice President of industry body
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
Paves way for CNS cancer test rollout
Subscribe To Our Newsletter & Stay Updated